Drs. French and Tanner are co-chairpersons.
Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New-Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society
Article first published online: 14 MAY 2004
Volume 45, Issue 5, pages 401–409, May 2004
How to Cite
French, J. A., Kanner, A. M., Bautista, J., Abou-Khalil, B., Browne, T., Harden, C. L., Theodore, W. H., Bazil, C., Stern, J., Schachter, S. C., Bergen, D., Hirtz, D., Montouris, G. D., Nespeca, M., Gidal, B., Marks, W. J., Turk, W. R., Fischer, J. H., Bourgeois, B., Wilner, A., Faught, R. E., Sachdeo, R. C., Beydoun, A. and Glauser, T. A. (2004), Efficacy and Tolerability of the New Antiepileptic Drugs, I: Treatment of New-Onset Epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia, 45: 401–409. doi: 10.1111/j.0013-9580.2004.06204.x
- Issue published online: 14 MAY 2004
- Article first published online: 14 MAY 2004
- Accepted February 3, 2004. Approved by the Quality Standards Subcommittee on July 26, 2003. Approved by the Therapeutics and Technology Assessment Subcommittee on October 18, 2003. Approved by the Practice Committee on November 8, 2003, and by the Board of Directors on January 17, 2004. This article was published in the April 27, 2004 issue of Neurology. Copyright AAN Enterprises, Inc.